-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...

-PTI Indian rice Swarna is amongst the most healthy varieties key food staple as researchers have found it has low risk of diabetes, says a leading rice research organisation. "Rice varieties such as India's most widely grown rice variety Swarna have a low glycemic index (GI) and varities such as Doongara from Australia and Basmati have medium GI," Melissa Fitzgerald of Manila-based International Rice Research Institute (IRRI)said in a statement. Low GI rice...

-The Times of India Rice isn't the diet villain as commonly thought. In fact, two types of rice commonly consumed by India's middle classes have now been found to have the lowest Glycemic Index (GI) — the measure of its ability to raise Blood Sugar levels after eating -- when compared with 233 other types of rice consumed around the world. Swarna and Mahsuri's GI levels were below 55. Another favourite among...

India is all set to unveil a path-breaking test for diabetes that will save both money and blood. The Indian Council of Medical Research (ICMR) is almost ready with a new digital finger-pricking Blood Sugar machine that will not require repeated use of testing strips. Significantly, it will cost less than Rs 2 per blood sample and require 1,000 times lesser blood than what glucose meters use now. Even better, it...

Does long-term intake of a special form of insulin prevent diabetes and heart problems, but cause cancer? The debate has been raging in medical circles for long. Now, an international study involving 12,000 pre-diabetics settles two parts of it, but leaves the other open for further research. Results of ORIGIN (Outcome Reduction with Initial Glargine Intervention) study presented in the wee hours of Tuesday at the annual meeting of the American...